:
Breakout Sessions
:
Doing Business Globally
:
6/18/2008 2:00 PM - 3:30 PM
:
San Diego Convention Center
:
24 BC
:
This panel will explore the key financial and policy features,
benchmarks and differentiators of global competitiveness in biopharmaceuticals research and development, and commercialization. The panel will examine differential product development costs in the United States, Canada, Europe, Asia
and Latin America. It will explore what various stakeholders should do now to prepare for globalization, and will discuss foreign outsourcing and how U.S. and other biopharmaceuticals
organizations and markets are approaching these issues.
:
1. Look at differential product development costs here and abroad.
2. Discuss what shareholders should be doing now to prepare for globalization.
3. Discuss whether foreign outsourcing in biopharmaceutical research and development is a given—or will U.S. biotechs buck the trend?
Leslie Platt, Esq - Chair
Counsel
Pillsbury Winthrop Shaw Pittman,LLP
Joshua Berlin
Executive Editor
Elsevier
Mike Fisher, PhD
Life Sciences Trade Specialist
UK Trade & Investment
Mario Brossi
Senior Representative for North America
Swiss Foreign Investment Agency
Qiao Joanne Jiang, PhD, MBA
Vice President
Fountain Medical Development
Robert Power
New York Stock Exchange